Export 90 results:
Author Title Type [ Year(Asc)]
Filters: Author is Cruz, F.  [Clear All Filters]
2017
Manso, M., Alexandre, B., Antunes-Lopes, T., Martins-da-Silva, C., & Cruz, F. (2017). Is the adjustable transobturator system ATOMS® useful for the treatment of male urinary incontinence in low to medium volume urological centers?. Actas Urologicas Espanolas.
Antunes-Lopes, T., Coelho, A., Pinto, R., Barros, S. C., et al. (2017). Author Reply. Urology, 99, 55 - 56.
Coelho, A., Antunes-Lopes, T., Gillespie, J., & Cruz, F. (2017). Beta-3 adrenergic receptor is expressed in acetylcholine-containing nerve fibers of the human urinary bladder: An immunohistochemical study. Neurourology and Urodynamics, 36(8), 1972 - 1980.
Chapple, C. R., Cruz, F., Deffieux, X., Milani, A. L., et al. (2017). Consensus Statement of the European Urology Association and the European Urogynaecological Association on the Use of Implanted Materials for Treating Pelvic Organ Prolapse and Stress Urinary Incontinence. European Urology, 72(3), 424 - 431.
Kennelly, M., Dmochowski, R., Schulte-Baukloh, H., Ethans, K., et al. (2017). Efficacy and safety of onabotulinumtoxinA therapy are sustained over 4 years of treatment in patients with neurogenic detrusor overactivity: Final results of a long-term extension study. Neurourology and Urodynamics, 36(2), 368 - 375.
Oliveira, R., Coelho, A., Charrua, A., Avelino, A., & Cruz, F. (2017). Expression of cleaved SNAP-25 after bladder wall injection of onabotulinumtoxina or abobotulinumtoxina: A comparative study in the mice. Neurourology and Urodynamics, 36(1), 86 - 90.
Antunes-Lopes, T., Coelho, A., Pinto, R., Barros, S. C., et al. (2017). Urinary Neurotrophin Levels Increase in Women With Stress Urinary Incontinence After a Midurethral Sling Procedure. Urology, 99, 49 - 56.
Matos, R., Serrão, P., Rodriguez, L., Birder, L. A., et al. (2017). The water avoidance stress induces bladder pain due to a prolonged alpha1A adrenoceptor stimulation. Naunyn-Schmiedeberg's Archives of Pharmacology, 390(8), 839 - 844.
2016
Avelino, A., Cruz, F., Panicker, J. N., & Liechti, M. D. (2016). Basic principles. In Practical Functional Urology (pp. 1 - 17).
Matos, R., Cordeiro, J. M., Coelho, A., Ferreira, S., et al. (2016). Bladder pain induced by prolonged peripheral alpha 1A adrenoceptor stimulation involves the enhancement of transient receptor potential vanilloid 1 activity and an increase of urothelial adenosine triphosphate release. Acta Physiologica, 218(4), 265 - 275.
De Carvalho, T. G. R., Pinto, R., Cruz, F., & Silva, J. (2016). Effect of onabotulinum toxin type a intraprostatic injection on the outcome of benign prostatic hyperplasia patients refractory to medical therapy: A 2-year follow-up study. Archivos Espanoles de Urologia, 69(10), 719 - 726.
Montorsi, F., Gandaglia, G., Chapple, C., Cruz, F., et al. (2016). Effectiveness and safety of silodosin in the treatment of lower urinary tract symptoms in patients with benign prostatic hyperplasia: A European phase IV clinical study (SiRE study). International Journal of Urology, 23(7), 572 - 579.
Martins-Silva, C., & Cruz, F. (2016). Efficacy and Safety of OnabotulinumtoxinA in Patients with Urinary Incontinence Due to Neurogenic Detrusor Overactivity: Update of the Pivotal Randomised, Double-blind, Placebo-controlled Trials. European Urology Focus, 2(3), 329 - 331.
Antunes-Lopes, T., C. da Silva, M., & Cruz, F. (2016). Evaluation of the Donor After Brain Death and Technique for Organ Procurement. European Urology, Supplements, 15(9), 390 - 396.
Coelho, A., Oliveira, R., Cruz, F., & Cruz, C. D. (2016). Impairment of sensory afferents by intrathecal administration of botulinum toxin A improves neurogenic detrusor overactivity in chronic spinal cord injured rats. Experimental Neurology, 285, 159 - 166.
Cruz, F. (2016). Re: Efficacy and Safety of Mirabegron Add-on Therapy to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Initial 4-week Solifenacin Monotherapy: A Randomised Double-blind Multicentre Phase 3B Study (BESIDE). European Urology, 70(5), 892.
2015
Cruz, C. D., Coelho, A., Antunes-Lopes, T., & Cruz, F. (2015). Biomarkers of spinal cord injury and ensuing bladder dysfunction. Advanced Drug Delivery Reviews, 82, 153 - 159.
Laterza, R. M., Sievert, K. - D., de Ridder, D., Vierhout, M. E., et al. (2015). Bladder function after radical hysterectomy for cervical cancer. Neurourology and Urodynamics, 34(4), 309 - 315.
Charrua, A., Pinto, R., Taylor, A., Canelas, A., et al. (2015). Can the adrenergic system be implicated in the pathophysiology of bladder pain syndrome/interstitial cystitis? A clinical and experimental study. Neurourology and Urodynamics, 34(5), 489 - 496.
Charrua, A., Cruz, C. D., Jansen, D., Rozenberg, B., et al. (2015). Co-administration of transient receptor potential vanilloid 4 (TRPV4) and TRPV1 antagonists potentiate the effect of each drug in a rat model of cystitis. BJU International, 115(3), 452 - 460.
Dinis, S., De Oliveira, J. T., Pinto, R., Cruz, F., et al. (2015). From bladder to systemic syndrome: Concept and treatment evolution of interstitial cystitis. International Journal of Women's Health, 7, 735 - 744.
Charrua, A., & Cruz, F. (2015). Intravesical Capsaicin and Resiniferatoxin for Bladder Disorders. In TRP Channels as Therapeutic Targets: From Basic Science to Clinical Use (pp. 119 - 127).
Frias, B., Santos, J., Morgado, M., Sousa, M. M., et al. (2015). The role of brain-derived neurotrophic factor (BDNF) in the development of neurogenic detrusor overactivity (NDO). Journal of Neuroscience, 35(5), 2146 - 2160.
Bunn, F., Kirby, M., Pinkney, E., Cardozo, L., et al. (2015). Is there a link between overactive bladder and the metabolic syndrome in women? A systematic review of observational studies. International Journal of Clinical Practice, 69(2), 199 - 217.
Coelho, A., Wolf-Johnston, A. S., Shinde, S., Cruz, C. D., et al. (2015). Urinary bladder inflammation induces changes in urothelial nerve growth factor and TRPV1 channels. British Journal of Pharmacology, 172(7), 1691 - 1699.

Pages


Home | Site Map | Contacts | Credits | Privacy & Cookies | Intranet | Social Networks |


rua alfredo allen, 208, 4200-135 porto - portugal | tel +351 220 408 800 | email: info@ibmc.up.pt | © copyright 2010 ibmc